ALSO READZydus Cadila receives final approval for Cyproheptadine Hydrochloride Tablets USP Zydus Cadila receives tentative approval for Sitagliptin and Metformin Hydrochloride Tablets Zydus receives final approval for Phentermine Hydrochloride Orally Disintegrating Tablets Strides Shasun receives approval for Memantine Hydrochloride Tablets Zydus Cadila receives final approval for Felbamate Tablets
From USFDAZydus Cadila has received final approval from USFDA to market Memantine Hydrochloride Tablets USP, 5 mg and 10 mg.
The drug is used in the treatment of moderate to severe dementia of Alzheimer's type and will be produced at the group's formulations manufacturing facility at Moraiya in Ahmedabad.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)